Abstract
Hypertonic solutions have been studied extensively in the treatment of hypovolemic shock, both in experimental and clinical models. Safety, efficacy, and long-term effects on animals and patients have been evaluated. The present article reviews indications, safety, mortality rates, and outcome in patients with hemorrhagic hypovolemic shock who were treated after admission with a hypertonic/hyperoncotic solution under strict observation in the emergency room.
Publication types
-
Clinical Trial
-
Randomized Controlled Trial
MeSH terms
-
Adolescent
-
Adult
-
Aged
-
Aged, 80 and over
-
Dextrans / administration & dosage
-
Dextrans / therapeutic use*
-
Double-Blind Method
-
Emergencies
-
Female
-
Follow-Up Studies
-
Humans
-
Male
-
Middle Aged
-
Plasma Substitutes / therapeutic use*
-
Prognosis
-
Saline Solution, Hypertonic / administration & dosage
-
Saline Solution, Hypertonic / therapeutic use*
-
Shock, Hemorrhagic / therapy*
-
Treatment Outcome
Substances
-
Dextrans
-
Plasma Substitutes
-
Saline Solution, Hypertonic